HOME >> BIOLOGY >> NEWS
Development of prostate drug based on UT Southwestern research

DALLAS June 24, 2003 A new finding revealing that the drug finasteride reduces the risk of prostate cancer by nearly 25 percent represents the culmination of three decades of research that began in the early 1970s at UT Southwestern Medical Center.

A study released online today by The New England Journal of Medicine shows that finasteride, which is already proven effective as a therapy for benign prostatic hyperplasia (BPH) or enlargement of the prostate also delays or prevents prostate cancer and reduces the risk of urinary problems. However, the drug has significant sexual side effects and may increase the risk of high-grade prostate cancer in some patients, the study reports. The study will appear in the July 17 print edition of the journal.

Finasteride inhibits the conversion of testosterone to dihydrotestosterone by the enzyme 5-alpha reductase. By doing so, it reduces the level of dihydrotestosterone the primary androgen in the prostate that is involved in the development of prostate cancer by 90 percent.

"Dr. Jean Wilson discovered the importance of the enzyme 5-alpha reductase in prostate disease almost 30 years ago," said Dr. John McConnell, UT Southwestern's executive vice president for health system affairs and a urologist.

"Since this discovery, UT Southwestern investigators have clearly demonstrated the role of this enzyme in BPH. The exciting information in this new article is that it clearly also has an impact on prostate cancer," said Dr. McConnell, UT Southwestern's former chairman of urology and acting director of the Harold C. Simmons Comprehensive Cancer Center.

The findings released today are the result of the Prostate Cancer Prevention Trial, a 7-year study involving 9,457 men. UT Southwestern participated as a trial site in this study.

Prostate cancer is the second-leading cause of death from cancer in men in the United States, and the most common non-skin cancer in America. The American Ca
'"/>

Contact: Rachel Horton
rachel.horton@utsouthwestern.edu
214-648-3404
UT Southwestern Medical Center
24-Jun-2003


Page: 1 2 3

Related biology news :

1. Origin and Development of the Vertebrate Traits
2. GlaxoSmithKline Drug Discovery and Development Research Grant Program 2004
3. 2nd Annual CDB Symposium: Developmental Remodeling (March 29 - 31, 2004; Kobe, Japan)
4. The Virus-Cancer Link: Examining the Role of Viruses in the Development of Cancer
5. Development of hair depends on development of the hair channel
6. ICSU to establish Science for Sustainable Development programme
7. Development of important immune cells relies on more complicated influences than scientist had thought
8. Forum on Research and Development in FY 2002 Budget
9. Population-Development-Environment in Namibia: background readings
10. Symposium Probes Impact Of Toxins On Development
11. Researchers Discover Mechanism Of Cleft Palate Development

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/30/2020)... ... April 29, 2020 , ... At the start of 2020 ... solutions for a wide range of industries including pharmaceutical and biopharmaceutical manufacturing, healthcare, ... the new decade, it was clear to company leadership that they would have ...
(Date:4/26/2020)... ... April 23, 2020 , ... SECO , ... FII Tech Growth managed by Fondo Italiano d’Investimento SGR, today announced a partnership ... development of Respira, a new non-invasive pulmonary ventilator created in response to the ...
(Date:4/23/2020)... ... 23, 2020 , ... Despite the current COVID-19 environment, MDG ... for the animal feed, human consumption, wastewater, and biotech sectors, and demand for ... from overseas competitors have become weakened or shut down completely, new inquiries come ...
Breaking Biology News(10 mins):
(Date:5/14/2020)... ... May 13, 2020 , ... In collaboration with Sartorius, Biocompare ... the Life Science Lab . The comprehensive information source was created for life ... liquid handling to contamination control. , The content hub features the latest guidance ...
(Date:5/5/2020)... ... May 05, 2020 , ... Smart Meter, ... of its iGlucose® LTE Cat-M Cellular Connected Diabetes Blood Glucose Monitor ... the industry’s newest and broadest cellular connectivity available, to provide patients with seamless ...
(Date:4/22/2020)... (PRWEB) , ... April 21, 2020 , ... ... FXIII chromogenic method for determination of FXIII. , Aniara Diagnostica, a multi-national distributor ... commitment to meeting today’s highest standards for product quality and cost-efficient delivery. ...
(Date:4/1/2020)... ... March 30, 2020 , ... ... latest product, ArmourGuard® RTU, an EPA-approved spray-on antimicrobial solution. As a first-of-its-kind technology ... that provides continual antimicrobial activity against microorganisms for up to 90 days. , ...
Breaking Biology Technology:
Cached News: